Priority Date: 17.06.16 (EP 20160175045)

NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TREATING HEPATITIS B INFECTION

  • Application ID: EP17732082
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). F. Hoffmann-La Roche AG is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Hoffmann Eitle PartmbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 146 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 17.06.2016 - Priority Date (EP 20160175045)
  • 21.12.2017 - Publication A1 (WO2017216390)
  • 24.04.2019 - Publication A1 (EP3472362)